Immune Response News and Research

RSS

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

Ortho Clinical Diagnostics launches COVID-19 antibody test

Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack. Testing kits are expected to be available in a few weeks.

From Ortho-Clinical Diagnostics, Inc. 6 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

Study investigates if the body's immune response to infections changes with seasons

Ground breaking new research is underway at the University of Surrey in collaboration with Columbia University to investigate if the body's immune response to infectious diseases and viruses, such as COVID-19, is altered by different seasons.

2 Apr 2020

COVID-19: What the illness looks like

With increasing information about COVID-19 disease gathered first-hand, a more accurate picture of the clinical features is coming together.

2 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

NJIT engineers design masks, shields and swabs to combat the surge in COVID-19 infections

As emergency response teams in the region scramble to acquire dwindling medical supplies to combat the surge in COVID-19 (coronavirus) infections, diverse members of the New Jersey Institute of Technology community - from engineers to physicists to advanced manufacturing specialists to students - are designing and fabricating devices to help address the shortfall.

31 Mar 2020

Novel, affordable pneumonia vaccine tested in human patients

A novel vaccine against pneumonia that is less expensive and more effective than those currently used in Brazil is being tested in human patients.

31 Mar 2020

Researchers develop chemically modified phage capsid that “stifles” influenza viruses

A new approach brings the hope of new therapeutic options for suppressing seasonal influenza and avian flu: On the basis of an empty - and therefore non-infectious - shell of a phage virus, researchers from Berlin have developed a chemically modified phage capsid that "stifles" influenza viruses.

31 Mar 2020

UDCA treatment affects C. diff life cycle, reduces inflammatory response in mice

Researchers from North Carolina State University have found that a commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile (C. diff) in vitro and reduce the inflammatory response to C. diff in mice.

30 Mar 2020

Researchers discover new way to refine production of retinal cells to treat blindness

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

30 Mar 2020

How long to a coronavirus vaccine?

The whole world is waiting for one. A vaccine is the only thing that could conceivably save the world from a horrifying cascade of deaths, other than a miracle, it seems.

29 Mar 2020

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population. So far, it has caused nearly 34,000 deaths – and the situation in the US is still worsening with over 142,000 cases and 2,489 deaths. In Australia, the number of cases has climbed to 4,093, with 16 fatalities.

29 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Scientists uncover key molecular mechanism underlying different aspects of sepsis

Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment.

27 Mar 2020

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Grifols today announces that it has entered into a formal collaboration with the US Government alongside other health agencies, to treat COVID-19 disease.

From GRIFOLS U.K. Ltd. 27 Mar 2020

Microbiome could help identify pre-cancer risk in women with HPV

A new study published in the open-access journal PLOS Pathogens in March 2020 reports the possible use of the bacteria Gardnerella found in the cervix and vagina of women with Human papillomavirus (HPV) infection, as a marker of precancerous change. The findings could help to find new methods of treatment that involve inducing changes in the microbiome to arrest the course of the disease.

26 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Immune Response News and Research

UC San Diego Health expands COVID-19 testing capacity

Ortho Clinical Diagnostics launches COVID-19 antibody test

St George's, University of London focuses entire research on tackling coronavirus

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Scientists find important clues to vaccine in SARS-CoV-2 genome

Study investigates if the body's immune response to infections changes with seasons

COVID-19: What the illness looks like

Putting an end to the pandemic

NJIT engineers design masks, shields and swabs to combat the surge in COVID-19 infections

Novel, affordable pneumonia vaccine tested in human patients

Researchers develop chemically modified phage capsid that “stifles” influenza viruses

UDCA treatment affects C. diff life cycle, reduces inflammatory response in mice

Researchers discover new way to refine production of retinal cells to treat blindness

How long to a coronavirus vaccine?

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

UC Davis launches two clinical trials to evaluate treatments for COVID-19

Scientists uncover key molecular mechanism underlying different aspects of sepsis

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Microbiome could help identify pre-cancer risk in women with HPV

New research initiative to investigate multi-species response to novel coronavirus

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News